Dingwei Zhao to Prostatic Neoplasms
This is a "connection" page, showing publications Dingwei Zhao has written about Prostatic Neoplasms.
Connection Strength
3.066
-
Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis. Oncogene. 2026 Sep; 45(36):3753-3764.
Score: 0.541
-
Divergent roles of SPOP and CHD1 in ACSL4 regulation reveal context-dependent vulnerabilities for targeting ferroptosis. Nat Commun. 2026 Jun 30; 17(1).
Score: 0.538
-
Histone methyltransferase ASH1L primes metastases and metabolic reprogramming of macrophages in the bone niche. Nat Commun. 2025 May 20; 16(1):4681.
Score: 0.498
-
Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies. Sci Transl Med. 2023 05 10; 15(695):eadf6724.
Score: 0.433
-
CHD1 Promotes Sensitivity to Aurora Kinase Inhibitors by Suppressing Interaction of AURKA with Its Coactivator TPX2. Cancer Res. 2022 09 02; 82(17):3088-3101.
Score: 0.413
-
Chromatin Regulator CHD1 Remodels the Immunosuppressive Tumor Microenvironment in PTEN-Deficient Prostate Cancer. Cancer Discov. 2020 09; 10(9):1374-1387.
Score: 0.352
-
Genetics and biology of prostate cancer. Genes Dev. 2018 09 01; 32(17-18):1105-1140.
Score: 0.078
-
An In Vivo Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer. Cancer Res. 2018 07 15; 78(14):3823-3833.
Score: 0.077
-
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer. Nature. 2017 02 23; 542(7642):484-488.
Score: 0.070
-
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression. Cancer Discov. 2016 Jan; 6(1):80-95.
Score: 0.065